LOCERYL

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug LOCERYL contains one active pharmaceutical ingredient (API):

1 Amorolfine UNII 741YH7379H - AMOROLFINE HYDROCHLORIDE

Amorolfine is a broad spectrum antimycotic. Amorolfine belongs to a new chemical class, and its fungicidal action is based on an alteration of the fungal cell membrane targeted primarily on sterol biosynthesis. The ergosterol content is reduced, and at the same time unusual sterically nonplanar sterols accumulate. Read about Amorolfine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOCERYL Nail lacquer	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AE16	Amorolfine	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AE Other antifungals for topical use
Discover more medicines within D01AE16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4010C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510100901165319, 510114110005703, 510115030005903, 510119010006103
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.598-03-04
Country: EE	Ravimiamet	Identifier(s): 1009572, 1009842, 1061042, 1740866, 1740877, 1742015, 1742026, 1860555
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 049551, 176955
Country: FR	Base de données publique des médicaments	Identifier(s): 65581507, 66895425
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 103552, 22885
Country: HK	Department of Health Drug Office	Identifier(s): 36522, 51795
Country: IE	Health Products Regulatory Authority	Identifier(s): 31437, 31457, 31462
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6003
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1012309, 1070286, 1078453, 1088352, 1088353, 1088642, 1088643, 1088691, 1089625, 1090866, 1093402
Country: MT	Medicines Authority	Identifier(s): MA117/00401
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6146
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100039460, 100189000, 100339830, 100359376, 100398838
Country: SG	Health Sciences Authority	Identifier(s): 07506P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7393061
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699586652622
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/13.9.2/0163